http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013165005-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2013165005-A1 |
| titleOfInvention | NOVEL COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ANTI-CANCER AGENT |
| abstract | Provided are novel compounds and anticancer agents having excellent cytotoxicity. Moreover, the method of manufacturing this novel compound simply is provided. Provided are a compound represented by the following formula (I) and an anticancer agent containing the compound as an active ingredient. A compound represented by the following formula (I) is produced in two stages using compounds represented by the following formulas (II) and (III) as starting materials. In formulas (I), (III), (IV), and (V), R 1 to R 2 and R a and R b are alkyl groups, R 3 is a leaving group, and n is an integer of 1 to 4. And two — (CH 2 ) n —NR 1 R 2 represent the same substituent. |
| priorityDate | 2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.